Polysorbate 80
Product Description
Hovione FarmaCiencia SA
-
PT
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Categories
Specifications
Hovione FarmaCiencia SA
-
PT
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
More Products from Hovione FarmaCiencia SA (43)
-
Product Minocycline Base
Antibiotics
ROUTE OF ADMINISTRATION: Oral, Injectable
REGULATORY STATUS: US DMF -
Product Minocycline Hydrochloride
ROUTE OF ADMINISTRATION: Oral, Injectable, Topical
REGULATORY STATUS: CEP, US DMF, JP DMF
-
Product Mometasone Furoate Anhydrous
High performance APIs for inhalation as well as other demanding applications. The diversity and experience in particle size reduction technologies provides our Customers with tailored made, highly reproducible particle size distributions. Low amorphous content and high stability w... -
Product Mometasone Furoate Monohydrate
Proven expertise in development of high performance APIs for demanding applications such as inhalation or nasal suspensions. The range of particle size reduction technologies enables the manufacture of tailor made material with high particle size distribution reproducibility across batches a... -
Product Olodaterol Sulphate
LABA/LAMAROUTE OF ADMINISTRATION: Inhalation
REGULATORY STATUS: DEV
-
Product Omadacycline
ROUTE OF ADMINISTRATION: Oral, Injectable
REGULATORY STATUS: DEV
-
Product Roxithromycin
A very high purity grade product available from a reliable European source
ROUTE OF ADMINISTRATION: Oral
REGULATORY STATUS: CEP, JP DMF
-
Product Salbutamol
LABA/ LAMAROUTE OF ADMINISTRATION: Inhalation
REGULATORY STATUS: GMP, TECH PACK
-
Product Salmeterol Xinafoate
Hovione has a proven track record in developing and manufacturing high performance APIs for the most demanding applications such as inhalation. With an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution re... -
Product Sancycline Hydrochloride
ROUTE OF ADMINISTRATION: Oral, Topical
REGULATORY STATUS: DEV -
Product Sarecycline
ROUTE OF ADMINISTRATION: Oral
REGULATORY STATUS: DEV -
Product Sodium Carbonate
ROUTE OF ADMINISTRATION: Injectable
REGULATORY STATUS: DEV, TECH PACK
Hovione FarmaCiencia SA resources (6)
-
News Hovione to create new campus and 100 jobs at New Jersey site
The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing -
News Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020. -
News Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19
Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol® -
News Hovione Technology unveils collaboration for new asthma product in Turkey
Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler. -
News Hovione's 'world's first' innovative inhaler receives prestigious design award
The 8Shot DPI is capable of delivering high doses of drug to the lungs.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance